Cardiac biomarkers stand as crucial elements in the landscape of cardiovascular medicine, providing indispensable information about heart health. These biomarkers, often identifiable proteins released into the bloodstream in response to specific cardiac events, are instrumental in the diagnosis, prognosis, and ongoing monitoring of various cardiovascular conditions. While troponins, creatine kinase-MB (CK-MB), and B-type natriuretic peptide (BNP) remain prominent players in this domain, ongoing research strives to unveil new biomarkers that can offer even more nuanced insights into heart function. The continuous evolution of cardiac biomarker research contributes to a deeper understanding of cardiovascular diseases, paving the way for innovative diagnostic tools and personalized treatment approaches. As healthcare professionals delve into expanding the repertoire of cardiac biomarkers, they aim to enhance the precision of diagnoses and ultimately improve patient outcomes in the realm of cardiovascular care.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation